| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,034 |
9,076 |
$635K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,891 |
2,525 |
$185K |
| 36415 |
Collection of venous blood by venipuncture |
2,428 |
2,177 |
$6K |
| 80061 |
Lipid panel |
783 |
733 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
85 |
82 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
84 |
76 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
164 |
75 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
160 |
154 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
196 |
188 |
$836.49 |
| 81001 |
|
15 |
14 |
$35.83 |
| 81003 |
|
13 |
12 |
$27.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
28 |
22 |
$24.26 |
| 3078F |
|
571 |
444 |
$0.60 |
| 3074F |
|
490 |
393 |
$0.57 |
| 3079F |
|
325 |
257 |
$0.54 |
| 3075F |
|
315 |
259 |
$0.35 |
| G0008 |
Administration of influenza virus vaccine |
43 |
39 |
$0.03 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
289 |
229 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
1,105 |
884 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
15 |
13 |
$0.00 |
| 99406 |
|
205 |
170 |
$0.00 |
| 3288F |
|
26 |
20 |
$0.00 |